Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic Basis For Metabolic Diseases Detected

30.06.2004


Oxford geneticists have closed in on the genetic basis for risk factors of metabolic diseases such as hypertension, obesity and diabetes.



Studying 1,300 patients and healthy volunteers from over 400 families across Oxfordshire, the research team located several variations in the DNA sequence of the lipid phosphate SHIP2 gene which are associated with an increased risk for a cluster of common and increasingly frequent disorders, referred to as the ’metabolic syndrome’ or ’Syndrome X’. Syndrome X, whose genetic basis is as yet unexplained, includes obesity, hypertension, type 2 diabetes and dyslipidaemia, and is a common risk factor for cardiovascular disease and atherosclerosis.

SHIP2 is a key cellular regulator of the biological effects of the hormone insulin which lowers the levels of blood sugar. Reduced insulin action, also called insulin resistance, is the common feature of the pathological components of the Syndrome X.


Dr Dominique Gauguier, Wellcome Senior Research Fellow at the Wellcome Trust Centre for Human Genetics at Oxford University, and his team identified 50 sequence variants in SHIP2 which were used to test their possible association with the different disease components of the Syndrome X diagnosed in the patients.

Dr Gauguier said: ’Epidemiological studies find that obesity, hypertension and type 2 diabetes are frequently associated, but we do not understand the exact causal relationships between these diseases, though environmental factors, for example diet and lifestyle, certainly play an important role. ‘Genetic studies have generally looked at these diseases independently. Our recent findings, which are among the first demonstrations of an association between gene sequence variants and the disease components of the Syndrome X, emphasise the need of extensive and accurate biological information in patients for tackling the genetics of metabolic disorders.’

’Another original feature of our research is that we have actually been able to translate our previous studies in a rat model of the Syndrome X, which carries a functional mutation in SHIP2, to human genetics.

’The next step is now to attempt a replication of our results in other large groups of patients characterised for features of the metabolic syndrome. Six research groups around the world are currently helping us do that.

’If we are correct, we may have found a tool for screening patients to see whether they are at increased risk of developing diabetes, hypertension, obesity or cardio-vascular disease. Our findings may have great potential for the prevention of metabolic disorders and, in predicting disease onset, may provide an opportunity for early intervention through changes in diet and lifestyle in people carrying the sequence variants in SHIP2.’

Barbara Hott | alfa
Further information:
http://www.ox.ac.uk
http://diabetes.diabetesjournals.org

More articles from Studies and Analyses:

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Disarray in the brain
18.12.2017 | Universität zu Lübeck

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Polymers Based on Boron?

18.01.2018 | Life Sciences

Bioengineered soft microfibers improve T-cell production

18.01.2018 | Life Sciences

World’s oldest known oxygen oasis discovered

18.01.2018 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>